Citadel Leads $50 Million Strategic Investment into Rezolve Ai to Accelerate AI-Powered Retail GlobeNewswire July 31, 2025 Institutional Conviction Capital with No Warrants or Protections Signals Long-Term Bet on Rezolve's High-ROI Growth Path Fresh Funding Follows Major 2025 Milestones Including $70M ARR, Tier-1 Retail Wins, and Microsoft & Google Alliances NEW YORK, July 31, 2025 […]
(NASDAQ:LSTA), BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other serious diseases, today announced that the Company will report its financial results for the second quarter ended June 30, 2025,
Inka Health Selected by OneMedNet to Lead AI-Driven Oncology Project Using Real-World Data for External Control Arms Reduce development timelines and costs, while improving access to life-saving treatments GlobeNewswire July 31, 2025 VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H, WKN: A3EKSZ) (“Onco” or the
(NasdaqGM:AVDL), DUBLIN, Ireland, July 31, 2025 (GLOBE NEWSWIRE) — Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines to transform lives, announced today that it will host a conference call and live webcast at 8:30 a.m. ET on Thursday, August 7, 2025, to provide a corporate update and discuss the Company's financial
Eco Oro Seeks Annulment of ICSID Tribunal Decision on Damages and Announces US$4.5 Million Financing GlobeNewswire July 31, 2025 VANCOUVER, British Columbia, July 31, 2025 (GLOBE NEWSWIRE) — Eco Oro Minerals Corp. (CSE: EOM) (“Eco Oro” or the “Company”) announces it has filed an application to annul the damages award issued on July 15, 2024
(NasdaqGM:AXINU), New York, New York, July 31, 2025 (GLOBE NEWSWIRE) — Axiom Intelligence Acquisition Corp 1 (Nasdaq: AXINU) (the “Company“) announced today that, commencing August 1, 2025, holders of the units sold in the Company's initial public offering may elect to separately trade the Company's Class A ordinary shares and rights included in the units.
VedTechBio Unveils Next-Gen Drug Discovery AI; Partners with AlphaMeld in Multi-Therapy Collaboration GlobeNewswire July 31, 2025 BENGALURU, India, July 31, 2025 (GLOBE NEWSWIRE) — VedTechBio Research Pvt. Ltd., a pioneer in AI-driven drug discovery, today announced major enhancements to its RxAgentAI(TM) platform, cutting drug discovery timelines in half, alongside a strategic collaboration with AlphaMeld Corporation
(NASDAQ:CTMX), SOUTH SAN FRANCISCO, Calif., July 31, 2025 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that it will report second quarter financial results on Thursday, August 7, 2025, after the close of U.S. markets. Following the announcement, the Company will host
OFA Group Advances Digital Asset Leadership in Architecture, Now Accepting Crypto Payments for Architectural and AI Solutions GlobeNewswire July 31, 2025 Strategic move enhances crypto treasury accumulation while positioning company at the forefront of digital asset adoption Los Angeles, CA, July 31, 2025 (GLOBE NEWSWIRE) — OFA Group (Nasdaq: OFAL) (“OFA” or “the Company”), an
(NASDAQ:LCUT), GARDEN CITY, N.Y., July 31, 2025 (GLOBE NEWSWIRE) — Lifetime Brands, Inc. (NasdaqGS: LCUT) (the “Company”), a leading global designer, developer and marketer of a broad range of branded consumer products used in the home, will release its second quarter 2025 financial results before market open on Thursday, August 7, 2025. The Company will